<DOC>
	<DOC>NCT02278302</DOC>
	<brief_summary>Study to investigate whether psychomotor performance which is necessary for safety driving a car or operating machinery and safely participating in daily life is changed by Aggrenox®. Also to investigate whether Aggrenox® impairs performance in combination with alcohol more than alcohol alone. Derived from this: Statement on whether a warning for drivers is necessary</brief_summary>
	<brief_title>Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<mesh_term>Dipyridamole</mesh_term>
	<mesh_term>Aspirin, Dipyridamole Drug Combination</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Salicylic Acid</mesh_term>
	<criteria>Race: Caucasian Men and women aged between 40 and 65 years Written and spoken command of German Ability to understand the nature and significance of the study Written informed consent to participate in the study Acute disease at the beginning of the study Any chronic disease in particular: Diseases for which the administration of the test drug was contraindicated: Severe coronary heart disease (e.g. unstable angina pectoris or recent myocardial infarction) Subvalvular aortic stenosis or hemodynamic instability, myocardial decompensation Severe hypotension, hypotonic collapse Any other cardiac disease (or case history of) Chronic obstructive lung disease Hepatic and renal dysfunction Diseases of the gastrointestinal tract Mental or neurologic diseases Alcoholism, alcohol abuse Case history of clinically relevant allergies (particularly against one of the ingredients of the test substance incl. paracetamol) Participation in another clinical study during the last two months preceding the study Women while pregnant or breastfeeding Women of childbearing age without safe contraception Psychotropic drugs during the last four weeks before the beginning of and during the study taking other medicaments regularly during the last two weeks before the beginning of and during the study (except for oral contraceptives, hormone replacement in women) Body weight outside the BodyMassIndex (BMI) + 4 Habits of life style having a presumable negative effect on the results of the performance test (e.g. shift work, extreme sports, blood donation within the last 4 weeks, &gt; 8 cups/glasses of caffeinecontaining beverages/day, &gt; 40 g alcohol/day, &gt;40 cigarettes/day) positive or no drug screening for barbiturates, benzodiazepines, tricyclic antidepressants and cannabinoids, amphetamines, cocaine, opiates Persons having been detained in an institution by judicial or official order Persons incapacitated or placed under provisional guardianship</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>